Healthcare cyber events are increasing - what was once a never-event is now a serious consideration. Laboratories must plan for extended downtime given the critical role laboratories play in patient care, it is imperative for labs to plan as though they could face extended periods without electronic systems to support laboratory operations.
Read MoreThe FDA has issued its long-awaited decision regarding the regulation of Lab Developed Testing (LDT) on May 6, 2024. This ruling holds significant implications for laboratory organizations, especially those currently offering testing developed in-house for patient care.
Read MoreMost labs are between a ‘rock and a hard place’ when thoroughly testing their auto-verification rules. Labs have a difficult decision - test rules or staff their production. This blog describes the difference between good and poor-quality rule testing and how to implement an efficient rule testing program to minimize effort but maximize rule performance.
Read MoreHappy Holidays from Talking Laboratories. Start out the new year with inspiration from our 2021 blogs.
Read MorePart 3 of our strategy for testing blog series focuses on collating data from your testing into a final Validation Summary report. The summarization of all the records and results brings together the lifecycle of the testing. Preparing a succinct and concise test summary document is the final documentation step in the release of your auto-verification software and logic into production
Read MoreMany laboratories struggle with how to develop and maintain a testing toolset for their automation system workflow and decision logic. They face many obstacles: how to create test plans, how to set up a testing environment, and how to identify qualified laboratory testers. Learn how to create a laboratory-specific testing framework that is reusable and can help you stay current with your system changes. Part 2 of our automation testing series details the best practices with pro-tips on how to create a durable testing regimen.
Read MoreStephanie Whitehead co-host from eLABorate and Anne Tate from Talking Laboratories discuss how to take advantage of career opportunities. They explore how taking risks combined with serendipity are key ingredients that can make all the difference. Learn how unexpected events and trust in yourself can help you leverage success in your career.
Read MoreMany laboratories struggle with the reality of making sure their new automation system works in their lab. How do you design a wet testing strategy to verify rules, workflow, and volume testing? Most labs don’t even know where to start. Learn how to design a user validation plan that is based on risk to assure your automation system operates as expected with the highest quality and efficiency.
Read MoreTesting your clinical automation system before you go live is always a challenge. There is no universal recipe or roadmap to guide laboratories on how to verify the operation of their automation according to their workflow and requirements. Learn how you can apply a risk-based approach to validate your automation system using a systematic methodology that takes the stress out of planning your testing program.
Read MoreLabs that continue to maintain paper-dependent processes will struggle to keep pace with the changing COVID-19 environment. Paper and manual based processes set up unintended and unforeseen bottlenecks in the laboratory and across the organization that are detrimental to your lab and organization. Learn why paper based systems could endanger your data integrity and quality more than you think.
Read MoreAn effective autoverification ROI should reflect your current and future state. The final step in any ROI design is to estimate your autoverification program benefits and costs to win approval and link it to your program’s overall value. We show you how to layout your autoverification ROI in a wholistic approach to bridge the clinical with the financial to secure stakeholder approval.
Read MoreThe process of building an autoverification ROI that tells your story can be an intimidating task. How do you gather costs and benefits in an overwhelming sea of laboratory data? Our ROI takes a simplified approach of leveraging your current results review data to build a strong ROI business case. Explore how to breakdown your data to successfully support your autoverification solution purchase.
Read MoreAnne Tate from Talking Laboratories contributed to a Dark Daily white paper that discusses how a laboratory can replace outreach manual order entry processes with automation. The white paper explores how laboratories can expand their revenue generation and capabilities by using automation to collect, process and report their data both horizontally and vertically to increase data use and reliability
Read MoreOur mission this year was to introduce our blog series that would inspire you to dig deeper when thinking about IT and informatics. No doubt, 2020 was an eventful year and Talking Laboratories wanted to be a part of the conversation. We hope that our blogs have been insightful and thought provoking. Check out our most popular blogs of 2020.
Read MoreWant to justify an autoverification investment or expansion of your rules-based program? A Return on investment (ROI) is an effective and powerful tool to tell your story to justify your business needs. A ROI based on clinical and operational improvements can connect the dots to prove your program value and get the funding you need to build your ideal autoverification program
Read MorePerforming a supply chain risk assessment has never been more important as the world becomes more interconnected and your product dependencies become more complex. If your lab is considering multiple COVID-19 analyzer platforms or products to shore up your testing coverage, a supply chain risk assessment will identify those overlapping supply chain issues
Read MorePerforming a supply chain risk assessment has never been more important, especially for COVID-19 testing kits and instrumentation. If you are considering multiple COVID-19 testing platforms to shore up your testing coverage, a new set of risk criteria should be considered to mitigate any supply chain disruptions. The rules have changed, and your risk assessment will help you build-in resilience into your supply chain.
Read MoreThe standardization of data transmission across the healthcare spectrum has never been more important or critical. Interoperability is the bridge between the medical community, our healthcare system and public health. One of the tools that can make a difference in the virus spread is data congruence to identify and manage the COVID-19 virus spread, support disease containment and influence future public policy.
Read More